Davis Polk advised ViewRay, Inc. in a direct registered offering of 8,382,643 shares of ViewRay’s common stock for proceeds to ViewRay of approximately $50 million. ViewRay’s common stock is listed on NASDAQ Global Market.
Headquartered in Oakwood Village, Ohio, ViewRay designs, manufactures and markets the first and only MRI-guided radiation therapy system that simultaneously images and treats cancer patients, called MRIdian.
The Davis Polk capital markets team included partner Alan F. Denenberg and associates Jeffrey C. Lau, Abhishek Kolay and Amy Tu. The tax team included partner Rachel D. Kleinberg and associate Erin Harvey. Members of the Davis Polk team are based in the Northern California and New York offices.